About Us
We’re committed to providing the tools to help you stay at the forefront of industry advancements. Through our series of articles, webinars and other educational resources, you’ll gain invaluable insights to help you maximize lab performance and provide a higher level of care to your patients.
We’re committed to providing the tools to help you stay at the forefront of industry advancements. Through our series of articles, webinars and other educational resources, you’ll gain invaluable insights to help you maximize lab performance and provide a higher level of care to your patients.
QuidelOrtho Corporation announced today that it has been granted CLIA Waiver from the U.S. Food and Drug Administration (FDA), applying to its new Sofia® 2 SARS Antigen+ FIA.
Search topics, categories and more...
Select multiple filters
Content Type
Category
Topic
About Us
